Central venous access devices in fluoropyrimidine therapy are associated with complications; however, reliable data are lacking regarding their natural history, associated complications and infusion ...

A pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy based on capecitabine: Polymorphisms in thymidilyate synthase and DNA repair genes. This is an ASCO ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the Neonav electrocardiogram (ECG) tip location system, a central venous access device (CVAD) placement platform developed by ...

Bluegrass Vascular picked up a CE mark for its central venous access catheter and is kicking off a limited commercial release for the device. The Surfacer Inside-Out Access Catheter System facilitates ...

Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...

Epidemiology and natural history of central venous access device (CVAD) use and infusion pump performance among patients (pts) treated for metastatic colorectal cancer (mCRC): Analysis from the ...

Among these, in 2023, the central venous access device segment accounted for the highest market share in the vascular access device market. This is owing to increasing incidence of cancer cases and ...